Twitter
Respirology cover

Case Reports covers

Join the APSR

FAPSR logo

15th Congress of the APSR

Main page

Manila, 2010


Scientific Programme

Overview

Major Topics

  • Asthma
  • Respiratory Neurobiology and Sleep
  • Critical Care Medicine
  • Bronchoscopy and Interventional Techniques
  • Pediatric Lung Disease
  • Respiratory Structure and Function
  • Pulmonary Circulation
  • Interstitial Lung Disease
  • Clinical Respiratory Medicine
  • Cell and Molecular Biology
  • Clinical Allergy & Immunology
  • Environmental & Occupational Health and Epidemiology
  • Respiratory Infections (non-TB)
  • Tuberculosis
  • COPD
  • Lung Cancer

Satellite Symposia Summary

  • November 22
    Satellite Symposium (12:00 - 13:30)
    1. Pfizer Vaccines (pdf)
  • November 23
    Satellite Symposia (12:00 - 13:30)
    1. Glaxo SmithKline
      Summit D, 4th Floor, PICC
      Challenges in chronic respiratory disease: familiar issues, different perspectives
      • 12:00 - 12:10 Chair's welcome and introduction
        Dr. Dina V Diaz, Philippines
      • 12:10 - 12:30 Challenges in respiratory disease for me: The public health officer
        Dr. Soe Nyunt-U, WHO
      • 12:30 - 12:50 Challenges in respiratory disease for me: The physician
        Dr. Dina V Diaz, Philippines
      • 12:50 - 13:20 Meeting the challenges today: are we making the most of what we've got?
        Dr. David Price, UK
      • 13:20 - 13:30 Q&A and Chair close
        Dr. Dina V Diaz, Philippines
    2. Boehringer Ingelheim
    3. Pfizer (pdf)
    4. Getz Pharma
    5. United Laboratories
      Banquet Hall, Second Floor, PICC
      Reaching New Heights of Confidence in RTI Management
      Speakers:Herbert Ho, M.D.
      Jubert Benedicto, M.D.
      Ronald Matias, PhD
      Teresita de Guia, M.D.
    6. Astra Zeneca
  • November 23
    Lunch Symposium (12:00 - 13:30)
    1. UAP (leaflet)
  • November 23
    Dinner Symposium (6:30 - 8:00 PM)
  • November 24
    Satellite Symposia (12:00 - 13:30)
    1. Otsuka
      Dynamic hyperinflation following hyperventilation on COPD
      • Opening Remarks
        Introduction of Speaker
        Abundio A Balgos, MD, FPCCP
      • Lecture Prof. Keisaku Fujimoto, MD, PhD
        Associated Professor of Respiratory Medicine
        Shinshu University School of Medicine
      • Moderator Shirley C Panganiban, MD, FPCCP
      • Words from the Sponsor Mr. SeongSu Ha
        Korea Otsuka International
        Asia Arab International PMM
        - Respitatory
    2. Bayer (pdf)
    3. NycoMed
      Summit D, 4th Floor, PICC
      Chairpersons: Dr. Sylvia Banal-Yang and Prof Peter Calverley
      • Welcome and Introduction
      • Current Insights into COPD as a disease of chronic inflammation
        Dr. Teresita De Guia
      • Treating inflammation in COPD
        Prof. Neil Barnes
      • PDE4 inhibitors for COPD: the evidence so far
        Prof. Peter Calverley
      • Panel Discussion
      • Conclusion
        Prof. Peter Calverley
    4. Janssen (pdf)
    5. Novartis
      Summit E/F, 4th Floor, PICC
      Evolution of bronchodilators for COPD; for better patient outcomes
      • Chair's welcome & introduction
        Claus Vogelmeier, Germany
      • The goals of COPD treatment: optimizing bronchodilation
        Christine Jenkins, Australia
      • The burden of COPD in Asia Pacific region
        Teresita de Guia, Philippines
      • Indacaterol: raising the standards for bronchodilators?
        Claus Vogelmeier, Germany
      • Q&A & Panel Discussion
        All
      • Chair's summary and close
        Claus Vogelmeier, Germany
    6. Pfizer